Africa’s largest pharmaceutical manufacturer started the week on the back foot, extending its recent losing streak with a 1.51% dip. The company’s share price, which has lost more than 38% of its value since end-December, is still feeling the effects of swinging into a R1.1bn annual loss last week.
STOCK HIGHLIGHT: Aspen loss still working through share price
Africa’s largest pharmaceutical manufacturer started the week on the back foot





Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.